Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS-Reference-Cited by-同舟云学术

Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS

Published:2019-04-03 Issue:4 Volume:53 Page:418-429
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Kim Sung Hwan¹,Kim Hyunjin¹,Lee Jin Hyup²,Park Jeen-Woo¹

Affiliation:

1. School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea;

2. Department of Food and Biotechnology, Korea University, Sejong, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10715762.2019.1597974

Reference56 articles.

1. Cancer Statistics, 2010

2. Therapy for metastatic melanoma: the past, present, and future

3. Malignant melanoma

4. Cancer Metastasis: Building a Framework

5. Final Version of 2009 AJCC Melanoma Staging and Classification

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis;International Journal of Molecular Sciences;2023-04-11

2. Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma;Journal of Oncology;2022-01-29

3. Redox Regulation of Metabolic Enzymes in Cancer;Oxidative Stress;2021

4. Adaptive redox homeostasis in cutaneous melanoma;Redox Biology;2020-10

5. Oxalomalate regulates the apoptosis and insulin secretory capacity in streptozotocin‐induced pancreatic β‐cells;Drug Development Research;2020-01-06